APA (7th ed.) Citation

Zuckermann, M., He, C., Andrews, J., Bagchi, A., Sloan-Henry, R., Bianski, B., . . . Baker, S. J. (2024, June). Capmatinib is an effective treatment for MET-fusion driven pediatric high-grade glioma and synergizes with radiotherapy. Molecular Cancer.

Chicago Style (17th ed.) Citation

Zuckermann, Marc, et al. "Capmatinib Is an Effective Treatment for MET-fusion Driven Pediatric High-grade Glioma and Synergizes with Radiotherapy." Molecular Cancer Jun. 2024.

MLA (9th ed.) Citation

Zuckermann, Marc, et al. "Capmatinib Is an Effective Treatment for MET-fusion Driven Pediatric High-grade Glioma and Synergizes with Radiotherapy." Molecular Cancer, Jun. 2024.